Insignia Health

Insignia Health is a healthcare technology and services company focused on improving patient activation, engagement, and self-management rather than developing therapeutic drugs. The company is best known for the Patient Activation Measure (PAM), a validated survey-based tool used by health systems, health plans, government programs, researchers, and life sciences organizations to assess an individual's knowledge, skills, and confidence in managing health. Its commercial offering includes PAM licensing, scoring, analytics, training, coaching methodologies, and the Flourish administration platform. Insignia Health was acquired by Phreesia in December 2021 and continues to operate as part of Phreesia's patient engagement portfolio. The business is healthcare-related, but it is not a biotech or pharmaceutical developer and does not have a traditional therapeutic pipeline.